<?xml version="1.0" encoding="UTF-8"?>
<p>The virus has a broad cell tropism; it disseminates preferentially in blood and lymph circulation early in the infection, but then infects monocytes, hepatocytes, adrenocortical cells, fibroblast, and epithelial cells.
 <xref rid="psp412510-bib-0018" ref-type="ref">
  <sup>18</sup>
 </xref>, 
 <xref rid="psp412510-bib-0019" ref-type="ref">
  <sup>19</sup>
 </xref>
 <italic>In vitro</italic> experiments suggest that the eclipse phase ranges between 2 and 15 hours.
 <xref rid="psp412510-bib-0020" ref-type="ref">
  <sup>20</sup>
 </xref>, 
 <xref rid="psp412510-bib-0021" ref-type="ref">
  <sup>21</sup>
 </xref> Cell apoptosis is caused by direct viral‐induced cytopathic effects but also by the release of multiple pro‐inflammatory mediators, including TNFα, interleukin (IL)‐1, IL‐6, and nitric oxide by activated monocytes/macrophages.
 <xref rid="psp412510-bib-0022" ref-type="ref">
  <sup>22</sup>
 </xref> Consistent with EVD pathogenesis, high levels of viral load and cytokines (IL6, IL10, IL1β, TNFα, MIP1α, MIP1β, and MCP1) at study inclusion were associated with a poor EVD prognosis.
 <xref rid="psp412510-bib-0023" ref-type="ref">
  <sup>23</sup>
 </xref>, 
 <xref rid="psp412510-bib-0024" ref-type="ref">
  <sup>24</sup>
 </xref>, 
 <xref rid="psp412510-bib-0025" ref-type="ref">
  <sup>25</sup>
 </xref>, 
 <xref rid="psp412510-bib-0026" ref-type="ref">
  <sup>26</sup>
 </xref>, 
 <xref rid="psp412510-bib-0027" ref-type="ref">
  <sup>27</sup>
 </xref> A global immunosuppression state along with altered adaptive responses, as suggested by the high level of T cells expressing inhibitory molecules CTLA‐4 and PD‐1, was also associated with fatal outcome.
 <xref rid="psp412510-bib-0025" ref-type="ref">
  <sup>25</sup>
 </xref> In contrast, a strong CD8 T cell response was observed in survivor patients,
 <xref rid="psp412510-bib-0028" ref-type="ref">
  <sup>28</sup>
 </xref> suggesting that the adaptive immune response is involved in viral clearance.
</p>
